Global Neurorehabilitation and Assistive Device Market Growth (Status and Outlook) 2023-2029

Global Neurorehabilitation and Assistive Device Market Growth (Status and Outlook) 2023-2029

The global Neurorehabilitation and Assistive Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Neurorehabilitation and Assistive Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Neurorehabilitation and Assistive Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Neurorehabilitation and Assistive Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Neurorehabilitation and Assistive Device players cover Medtronic, Abbott Laboratories, Boston Scientific, Bioness, Hocoma, Neuronetics, Magstim, Ekso Bionics and Alter G, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Neurorehabilitation and Assistive Device Industry Forecast” looks at past sales and reviews total world Neurorehabilitation and Assistive Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Neurorehabilitation and Assistive Device sales for 2023 through 2029. With Neurorehabilitation and Assistive Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurorehabilitation and Assistive Device industry.

This Insight Report provides a comprehensive analysis of the global Neurorehabilitation and Assistive Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurorehabilitation and Assistive Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurorehabilitation and Assistive Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurorehabilitation and Assistive Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurorehabilitation and Assistive Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Neurorehabilitation and Assistive Device market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Brain Neurorehabilitation and Assistive Device
Arms Neurorehabilitation and Assistive Device
Legs Neurorehabilitation and Assistive Device
Other

Segmentation by application
Hospital
Rehabilitation Center
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma
Neuronetics
Magstim
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical



Please note: The report will take approximately 2 business days to prepare and deliver.